Sponsor or institution

Clinical trials and research at Spanish Oncology Genito-Urinary Group

• 2Clinical trials
• 4Countries

All recruiting trials (2)

• Observing the effectiveness of funded drugs for genitourinary cancers

  This study looks at how well new cancer drugs work for patients with genitourinary tumors in Spain by collecting real-life data from their treatment experiences.

  Recruiting at 82 sites Spanish Oncology Genito-Urinary Group · Albacete, Albacete and 83 other locations · NCT06724159

• Erdafitinib with or without Cetrelimab for muscle-invasive bladder cancer

  This study is testing if a new drug called erdafitinib, alone or with another drug called cetrelimab, can help people with muscle-invasive bladder cancer who can’t take certain chemotherapy drugs before their surgery.

  Recruiting at 19 sites Phase 2 Spanish Oncology Genito-Urinary Group · Clermont-Ferrand and 22 other locations · NCT06511648

Quick answers

How many clinical trials run by Spanish Oncology Genito-Urinary Group are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in Spain (2 trials), France (1 trial), Italy (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →